Non–Small Cell Lung Cancer: Other Actionable Mutations
2 Visualizzazioni
• 07/04/23
0
0
Incorporare
administrator
Iscritti
Corey J. Langer, MD; V****iliki Papadimitrakopoulou, MD; and Hossein Borghaei, DO, elucidate the potential value of less common actionable mutations in determining appropriate treatment for patients with non–small cell lung cancer.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti